Although only two studies were of high enough quality to be included in the review, pooled data showed a 2.5-fold increased risk of Parkinson's disease among patients taking zolpidem (Ambien), Salman Hussain, PhD, of Hamdard University in New Delhi in India, reported at the Movement Disorders Society meeting here.
https://www.medpagetoday.com/MeetingCoverage/MDS/65841?xid=NL_breakingnews_2017-06-07&eun=g721819d0r
No comments:
Post a Comment